11821
The main clinical features of this 58-year - old female patient were laboratory evidence of leucopenia and cholestasis , and biopsy features of fatty liver parenchyma degeneration with granulocytic portal infiltration and bile stasis , demonstrated 20 days after the initiation of antithyroid therapy with 20 mg methimazole daily .
 adverse effect: bile stasis, methimazole; adverse effect: cholestasis, methimazole; adverse effect: fatty liver parenchyma degeneration, methimazole; adverse effect: granulocytic portal infiltration, methimazole; adverse effect: leucopenia, methimazole
Given options, please tell me the relationships of all the listed entity pairs.Output format is "relation1: word1, word2; relation2: word3, word4". 
Option: adverse effect 
Text: {0} 
 Entity Pairs:  bile stasis, methimazole; cholestasis, methimazole; fatty liver parenchyma degeneration, methimazole; granulocytic portal infiltration, methimazole; leucopenia, methimazole 
Answer:
 adverse effect: bile stasis, methimazole; adverse effect: cholestasis, methimazole; adverse effect: fatty liver parenchyma degeneration, methimazole; adverse effect: granulocytic portal infiltration, methimazole; adverse effect: leucopenia, methimazole